Drug details

Corphedra Injection (ephedrine sulfate)

type of Alpha/Beta Adrenergic Agonists

Corphedra (ephedrine sulfate injection), for intravenous use is an alpha- and beta-adrenergic agonist and a norepinephrine-releasing agent indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• lightheadedness,
• shortness of breath,
• dizziness,
• seizure,
• high blood pressure,
• fainting,
• weakness,
• chest pain or pressure,
• trouble speaking,
• sudden numbness or weakness in the face, arm, or leg (especially on one side of the body),
• sudden confusion,
• difficulty understanding speech,
• loss of balance,
• lack of coordination,
• trouble walking,  
• pain in the jaw, neck, or back,
• irregular heartbeat, and
• death

The following drugs are related to Corphedra Injection, either as a replacement or used together:

• Aldomet (methyldopa)
• Uroxatral (alfuzosin hcl)
• Hexalen (altretamine)
• Saphris (asenapine sublingual tablets)
• Rexulti (brexpiprazole tablets)
• Parlodel (bromocriptine mesylate)
• Coreg (carvedilol)
• Coreg CR (carvedilol phosphate extended-release)
• Jardiance (empagliflozin tablets)
• Rezipres (ephedrine hydrochloride)
• Fanapt (iloperidone tablets)
• Haldol (haloperidol injection)
• Hytrin (terazosin hcl)
• Immphentiv (phenylephrine hydrochloride injection)
• Invega (paliperidone)
• Proamatine (midodrine hydrochloride)